Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.45K Hold
12,500
﹤0.01% 1761
2026
Q1
$7.86K Hold
12,500
﹤0.01% 1588
2025
Q4
$11K Buy
+12,500
New +$13.4K ﹤0.01% 1235
2025
Q3
Sell
-12,500
Closed -$19.6K 1250
2025
Q2
$19.6K Sell
12,500
-14,591
-54% -$27.2K ﹤0.01% 1446
2025
Q1
$71.5K Buy
+27,091
New +$109K ﹤0.01% 1424
2024
Q4
Sell
-13,016
Closed -$43.2K 1828
2024
Q3
$43.2K Buy
+13,016
New +$44.2K ﹤0.01% 2006
2024
Q2
Sell
-39,673
Closed -$160K 2151
2024
Q1
$160K Buy
39,673
+22,578
+132% +$85.2K ﹤0.01% 1531
2023
Q4
$95.6K Buy
+17,095
New +$98.2K ﹤0.01% 1592

Other funds holding DCGO

Centiva Capital's DCGO Position: Q2 2026 in Review

Centiva Capital held its DocGo (DCGO) position steady in Q2 2026 at 12,500 shares worth $6.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

Centiva Capital first reported a position in DCGO in Q4 2023 and has held it in 8 quarters since. The position peaked at $160K in Q1 2024. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Centiva Capital held 12,500 shares of DocGo worth $6.45K as of Q2 2026.
  • Centiva Capital left its DocGo share count unchanged in Q2 2026.
  • DocGo made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1761 holding.
  • Centiva Capital first reported a position in DocGo in Q4 2023 and has held it in 8 quarters since.
  • Centiva Capital's DocGo position peaked at $160K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.